An experimental fentanyl vaccine showed promise in an early-stage trial

An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial, the drugmaker, ARMR Sciences, said Wednesday. It’s the first fentanyl vaccine to be tested in humans, and if it proves effective in larger trials, experts say it would mark a major breakthrough in efforts to combat the opioid epidemic in the United States.

For Subscribers

FOR SUBSCRIBERSIsrael’s Arab parties emerge from election as kingmakers, and a focus of anger

FOR SUBSCRIBERSCruise company had troubled history before abandoning passengers in Cambodia

FOR SUBSCRIBERSDark money group seeks to undercut Republican candidates with pro-gun voters

FOR SUBSCRIBERSAmy Acton’s mom, who called her a ‘liar’ in Ramaswamy ad, faced years of turmoil, records show

FOR SUBSCRIBERSFDA plans to update nutrition rules for infant formula

FOR SUBSCRIBERSHow French student protests over schools escalated into nationwide riots

FOR SUBSCRIBERSTrump says Alaska’s Democratic Senate candidate should be prosecuted over Dan Sullivan ballot dispute

FOR SUBSCRIBERSElection betting odds became less accurate as primaries neared, report finds

FOR SUBSCRIBERSHow Colorado became a battlefield in the legal fight between LGBTQ and religious rights

FOR SUBSCRIBERSHow California prison reforms helped free a serial rapist called ‘America’s creepiest heir’

FOR SUBSCRIBERSTrump’s final campaign swing is taking on a darker tone

FOR SUBSCRIBERSMel Robbins has midterms advice for you

FOR SUBSCRIBERSFlorida cop charged with possessing dead man’s house had history of misconduct

FOR SUBSCRIBERSDHS hack exposes 40,000 employee names and undercover ICE agents, activists say

FOR SUBSCRIBERSRising diesel prices hit school districts hard ahead of the midterm elections

For Subscribers

FOR SUBSCRIBERSIsrael’s Arab parties emerge from election as kingmakers, and a focus of anger

FOR SUBSCRIBERSCruise company had troubled history before abandoning passengers in Cambodia

FOR SUBSCRIBERSDark money group seeks to undercut Republican candidates with pro-gun voters

FOR SUBSCRIBERSAmy Acton’s mom, who called her a ‘liar’ in Ramaswamy ad, faced years of turmoil, records show

FOR SUBSCRIBERSFDA plans to update nutrition rules for infant formula

FOR SUBSCRIBERSHow French student protests over schools escalated into nationwide riots

FOR SUBSCRIBERSTrump says Alaska’s Democratic Senate candidate should be prosecuted over Dan Sullivan ballot dispute

FOR SUBSCRIBERSElection betting odds became less accurate as primaries neared, report finds

FOR SUBSCRIBERSHow Colorado became a battlefield in the legal fight between LGBTQ and religious rights

FOR SUBSCRIBERSHow California prison reforms helped free a serial rapist called ‘America’s creepiest heir’

FOR SUBSCRIBERSTrump’s final campaign swing is taking on a darker tone

FOR SUBSCRIBERSMel Robbins has midterms advice for you

FOR SUBSCRIBERSFlorida cop charged with possessing dead man’s house had history of misconduct

FOR SUBSCRIBERSDHS hack exposes 40,000 employee names and undercover ICE agents, activists say

FOR SUBSCRIBERSRising diesel prices hit school districts hard ahead of the midterm elections

Just a moment.

We are getting your experience ready.

Follow relevant topics

An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial, the drugmaker, ARMR Sciences, said Wednesday. It’s the first fentanyl vaccine to be tested in humans, and if it proves effective in larger trials, experts say it would mark a major breakthrough in efforts to combat the opioid epidemic in the United States.

For Subscribers

FOR SUBSCRIBERSIsrael’s Arab parties emerge from election as kingmakers, and a focus of anger

FOR SUBSCRIBERSCruise company had troubled history before abandoning passengers in Cambodia

FOR SUBSCRIBERSDark money group seeks to undercut Republican candidates with pro-gun voters

FOR SUBSCRIBERSAmy Acton’s mom, who called her a ‘liar’ in Ramaswamy ad, faced years of turmoil, records show

FOR SUBSCRIBERSFDA plans to update nutrition rules for infant formula

FOR SUBSCRIBERSHow French student protests over schools escalated into nationwide riots

FOR SUBSCRIBERSTrump says Alaska’s Democratic Senate candidate should be prosecuted over Dan Sullivan ballot dispute

FOR SUBSCRIBERSElection betting odds became less accurate as primaries neared, report finds

FOR SUBSCRIBERSHow Colorado became a battlefield in the legal fight between LGBTQ and religious rights

FOR SUBSCRIBERSHow California prison reforms helped free a serial rapist called ‘America’s creepiest heir’

FOR SUBSCRIBERSTrump’s final campaign swing is taking on a darker tone

FOR SUBSCRIBERSMel Robbins has midterms advice for you

FOR SUBSCRIBERSFlorida cop charged with possessing dead man’s house had history of misconduct

FOR SUBSCRIBERSDHS hack exposes 40,000 employee names and undercover ICE agents, activists say

FOR SUBSCRIBERSRising diesel prices hit school districts hard ahead of the midterm elections

For Subscribers

FOR SUBSCRIBERSIsrael’s Arab parties emerge from election as kingmakers, and a focus of anger

FOR SUBSCRIBERSCruise company had troubled history before abandoning passengers in Cambodia

FOR SUBSCRIBERSDark money group seeks to undercut Republican candidates with pro-gun voters

FOR SUBSCRIBERSAmy Acton’s mom, who called her a ‘liar’ in Ramaswamy ad, faced years of turmoil, records show

FOR SUBSCRIBERSFDA plans to update nutrition rules for infant formula

FOR SUBSCRIBERSHow French student protests over schools escalated into nationwide riots

FOR SUBSCRIBERSTrump says Alaska’s Democratic Senate candidate should be prosecuted over Dan Sullivan ballot dispute

FOR SUBSCRIBERSElection betting odds became less accurate as primaries neared, report finds

FOR SUBSCRIBERSHow Colorado became a battlefield in the legal fight between LGBTQ and religious rights

FOR SUBSCRIBERSHow California prison reforms helped free a serial rapist called ‘America’s creepiest heir’

FOR SUBSCRIBERSTrump’s final campaign swing is taking on a darker tone

FOR SUBSCRIBERSMel Robbins has midterms advice for you

FOR SUBSCRIBERSFlorida cop charged with possessing dead man’s house had history of misconduct

FOR SUBSCRIBERSDHS hack exposes 40,000 employee names and undercover ICE agents, activists say

FOR SUBSCRIBERSRising diesel prices hit school districts hard ahead of the midterm elections

Just a moment.

We are getting your experience ready.

Follow relevant topics